Suppr超能文献

兔离体灌注肾对内皮素-1和大内皮素-1的代谢

The metabolism of endothelin-1 and big endothelin-1 by the isolated perfused kidney of the rabbit.

作者信息

Kaw S, Warner T D, Vane J R

机构信息

William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, England.

出版信息

J Cardiovasc Pharmacol. 1993;22 Suppl 8:S65-8. doi: 10.1097/00005344-199322008-00019.

Abstract

The activity of human big endothelin-1 (bET-1) or endothelin-1 (ET-1) was investigated in the isolated perfused kidney of the rabbit. In some experiments the effluent superfused a rabbit jugular vein (RbJV) or rat colon (RC), and bolus doses of bET-1 or ET-1 were administered either directly over the tissue (OT) or through the kidney (TK). When injected OT, the contractile responses of the RbJV to ET-1 were > or = 100-200 times more than those to bET-1. However, at least 10 times the ET-1 dose given OT was needed TK to produce an equivalent contraction of the RbJV, showing that ET-1 was being inactivated or removed by the kidney. Injections of bET-1 TK produced increases in perfusion pressure of a magnitude 1/25th of those of ET-1. In some experiments administration of bET-1 TK was associated with the release into the perfusate of an ET-1-like factor that contracted the RbJV, but not the RC (used to detect any angiotensin II release), at doses that had little effect when administered OT, suggesting that bET-1 was being activated by the kidney. Phosphoramidon (10 microM) infused TK blocked (92 +/- 1% inhibition) the renal responses to bET-1 and reduced the overflow of ET-1-like material onto the tissues without affecting ET-1-induced renal vasoconstriction. Incubation of bET-1 with rabbit renal cortical microsomes (100 micrograms protein) resulted in the generation of ET-1-like activity, as assessed by bioassay, which was inhibited by phosphoramidon (10 microM).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在兔的离体灌注肾中研究了人 big 内皮素 -1(bET -1)或内皮素 -1(ET -1)的活性。在一些实验中,流出液灌注兔颈静脉(RbJV)或大鼠结肠(RC),并将大剂量的 bET -1 或 ET -1 直接注射到组织上(OT)或通过肾脏(TK)给药。当经 OT 注射时,RbJV 对 ET -1 的收缩反应比对 bET -1 的反应大 100 - 200 倍或更高。然而,经 TK 给药时,产生与经 OT 给药产生等效 RbJV 收缩所需的 ET -1 剂量至少是经 OT 给药剂量的 10 倍,这表明 ET -1 被肾脏灭活或清除。经 TK 注射 bET -1 使灌注压升高的幅度仅为 ET -1 的 1/25。在一些实验中,经 TK 给予 bET -1 与一种能使 RbJV 收缩但不能使 RC(用于检测任何血管紧张素 II 释放)收缩的 ET -1 样因子释放到灌注液中有关,该因子经 OT 给药时剂量效应很小,提示 bET -1 被肾脏激活。经 TK 注入磷酰胺素(10 μM)可阻断(抑制率为 92 ± 1%)肾脏对 bET -1 的反应,并减少 ET -1 样物质向组织的溢出,而不影响 ET -1 诱导的肾血管收缩。用兔肾皮质微粒体(100 μg 蛋白质)孵育 bET -1 可产生 ET -1 样活性,通过生物测定评估,该活性可被磷酰胺素(10 μM)抑制。(摘要截短至 250 字)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验